company background image
CSII logo

Cardiovascular Systems NasdaqGS:CSII Stock Report

Last Price

US$20.00

Market Cap

US$844.0m

7D

0.1%

1Y

1.6%

Updated

27 Apr, 2023

Data

Company Financials +

Cardiovascular Systems, Inc.

NasdaqGS:CSII Stock Report

Market Cap: US$844.0m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

CSII Stock Overview

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally.

CSII fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Cardiovascular Systems, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cardiovascular Systems
Historical stock prices
Current Share PriceUS$20.00
52 Week HighUS$20.57
52 Week LowUS$12.26
Beta0.74
1 Month Change0.70%
3 Month Change49.48%
1 Year Change1.63%
3 Year Change-52.38%
5 Year Change-25.90%
Change since IPO123.46%

Recent News & Updates

We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

Feb 03
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

Recent updates

We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

Feb 03
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate

We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely

Oct 12
We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely

Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates

Aug 03

Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns

Nov 05
Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns

Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?

Oct 09
Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?

At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?

Sep 18
At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?

Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?

Jun 24
Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?

Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Jun 03
Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?

We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow

Apr 29
We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow

Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Mar 17
Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?

Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain

Feb 10
Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain

Cardiovascular Systems misses on revenue

Feb 03

Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares

Dec 11
Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares

Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation

Nov 06

Shareholder Returns

CSIIUS Medical EquipmentUS Market
7D0.1%2.3%0.2%
1Y1.6%12.8%28.1%

Return vs Industry: CSII exceeded the US Medical Equipment industry which returned -0.1% over the past year.

Return vs Market: CSII exceeded the US Market which returned -5.3% over the past year.

Price Volatility

Is CSII's price volatile compared to industry and market?
CSII volatility
CSII Average Weekly Movement14.0%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: CSII's share price has been volatile over the past 3 months.

Volatility Over Time: CSII's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1989725Scott Wardhttps://www.csi360.com

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions.

Cardiovascular Systems, Inc. Fundamentals Summary

How do Cardiovascular Systems's earnings and revenue compare to its market cap?
CSII fundamental statistics
Market capUS$843.96m
Earnings (TTM)-US$37.87m
Revenue (TTM)US$239.84m

3.5x

P/S Ratio

-22.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CSII income statement (TTM)
RevenueUS$239.84m
Cost of RevenueUS$66.22m
Gross ProfitUS$173.63m
Other ExpensesUS$211.49m
Earnings-US$37.87m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.90
Gross Margin72.39%
Net Profit Margin-15.79%
Debt/Equity Ratio0%

How did CSII perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.